Global Crohn's Disease Diagnostic and Therapeutic Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 324808
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 165
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Crohn's Disease Diagnostic and Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Crohn's Disease Diagnostic and Therapeutic market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinic accounting for % of the Crohn's Disease Diagnostic and Therapeutic global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Blood Tests segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Crohn's Disease Diagnostic and Therapeutic include AbbVie, Celgene Corporation, Genetech, Janssen Biotech, and Johnson & Johnson, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Crohn's Disease Diagnostic and Therapeutic market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Blood Tests

Fecal Test

Colonoscopy

Flexible Sigmoidoscopy

Computerized Tomography

Magnetic Resonance Imaging

Capsule Endoscopy

Market segment by Application, can be divided into

Clinic

Hospital

Market segment by players, this report covers

AbbVie

Celgene Corporation

Genetech

Janssen Biotech

Johnson & Johnson

Pfizer

Prometheus Laboratories

Salix Pharmaceuticals

Takeda's Pharmaceutical

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Crohn's Disease Diagnostic and Therapeutic product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Crohn's Disease Diagnostic and Therapeutic, with revenue, gross margin and global market share of Crohn's Disease Diagnostic and Therapeutic from 2019 to 2022.

Chapter 3, the Crohn's Disease Diagnostic and Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Crohn's Disease Diagnostic and Therapeutic market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Crohn's Disease Diagnostic and Therapeutic research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Crohn's Disease Diagnostic and Therapeutic

1.2 Classification of Crohn's Disease Diagnostic and Therapeutic by Type

1.2.1 Overview: Global Crohn's Disease Diagnostic and Therapeutic Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type in 2021

1.2.3 Blood Tests

1.2.4 Fecal Test

1.2.5 Colonoscopy

1.2.6 Flexible Sigmoidoscopy

1.2.7 Computerized Tomography

1.2.8 Magnetic Resonance Imaging

1.2.9 Capsule Endoscopy

1.3 Global Crohn's Disease Diagnostic and Therapeutic Market by Application

1.3.1 Overview: Global Crohn's Disease Diagnostic and Therapeutic Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Clinic

1.3.3 Hospital

1.4 Global Crohn's Disease Diagnostic and Therapeutic Market Size & Forecast

1.5 Global Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast by Region

1.5.1 Global Crohn's Disease Diagnostic and Therapeutic Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Crohn's Disease Diagnostic and Therapeutic Market Size by Region, (2017-2022)

1.5.3 North America Crohn's Disease Diagnostic and Therapeutic Market Size and Prospect (2017-2028)

1.5.4 Europe Crohn's Disease Diagnostic and Therapeutic Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size and Prospect (2017-2028)

1.5.6 South America Crohn's Disease Diagnostic and Therapeutic Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Crohn's Disease Diagnostic and Therapeutic Market Drivers

1.6.2 Crohn's Disease Diagnostic and Therapeutic Market Restraints

1.6.3 Crohn's Disease Diagnostic and Therapeutic Trends Analysis

2 Company Profiles

2.1 AbbVie

2.1.1 AbbVie Details

2.1.2 AbbVie Major Business

2.1.3 AbbVie Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.1.4 AbbVie Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 AbbVie Recent Developments and Future Plans

2.2 Celgene Corporation

2.2.1 Celgene Corporation Details

2.2.2 Celgene Corporation Major Business

2.2.3 Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.2.4 Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 Celgene Corporation Recent Developments and Future Plans

2.3 Genetech

2.3.1 Genetech Details

2.3.2 Genetech Major Business

2.3.3 Genetech Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.3.4 Genetech Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Genetech Recent Developments and Future Plans

2.4 Janssen Biotech

2.4.1 Janssen Biotech Details

2.4.2 Janssen Biotech Major Business

2.4.3 Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.4.4 Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Janssen Biotech Recent Developments and Future Plans

2.5 Johnson & Johnson

2.5.1 Johnson & Johnson Details

2.5.2 Johnson & Johnson Major Business

2.5.3 Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.5.4 Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Johnson & Johnson Recent Developments and Future Plans

2.6 Pfizer

2.6.1 Pfizer Details

2.6.2 Pfizer Major Business

2.6.3 Pfizer Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.6.4 Pfizer Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Pfizer Recent Developments and Future Plans

2.7 Prometheus Laboratories

2.7.1 Prometheus Laboratories Details

2.7.2 Prometheus Laboratories Major Business

2.7.3 Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.7.4 Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7.5 Prometheus Laboratories Recent Developments and Future Plans

2.8 Salix Pharmaceuticals

2.8.1 Salix Pharmaceuticals Details

2.8.2 Salix Pharmaceuticals Major Business

2.8.3 Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.8.4 Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8.5 Salix Pharmaceuticals Recent Developments and Future Plans

2.9 Takeda's Pharmaceutical

2.9.1 Takeda's Pharmaceutical Details

2.9.2 Takeda's Pharmaceutical Major Business

2.9.3 Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Product and Solutions

2.9.4 Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9.5 Takeda's Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Crohn's Disease Diagnostic and Therapeutic Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Crohn's Disease Diagnostic and Therapeutic Players Market Share in 2021

3.2.2 Top 10 Crohn's Disease Diagnostic and Therapeutic Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Crohn's Disease Diagnostic and Therapeutic Players Head Office, Products and Services Provided

3.4 Crohn's Disease Diagnostic and Therapeutic Mergers & Acquisitions

3.5 Crohn's Disease Diagnostic and Therapeutic New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Crohn's Disease Diagnostic and Therapeutic Revenue and Market Share by Type (2017-2022)

4.2 Global Crohn's Disease Diagnostic and Therapeutic Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5.1 Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Application (2017-2022)

5.2 Global Crohn's Disease Diagnostic and Therapeutic Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6.1 North America Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2028)

6.2 North America Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2028)

6.3 North America Crohn's Disease Diagnostic and Therapeutic Market Size by Country

6.3.1 North America Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2028)

6.3.2 United States Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

6.3.3 Canada Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

6.3.4 Mexico Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7.1 Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2028)

7.2 Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2028)

7.3 Europe Crohn's Disease Diagnostic and Therapeutic Market Size by Country

7.3.1 Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2028)

7.3.2 Germany Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

7.3.3 France Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

7.3.5 Russia Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

7.3.6 Italy Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2028)

8.2 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2028)

8.3 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Market Size by Region

8.3.1 Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Region (2017-2028)

8.3.2 China Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

8.3.3 Japan Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

8.3.4 South Korea Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

8.3.5 India Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

8.3.7 Australia Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9.1 South America Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2028)

9.2 South America Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2028)

9.3 South America Crohn's Disease Diagnostic and Therapeutic Market Size by Country

9.3.1 South America Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2028)

9.3.2 Brazil Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

9.3.3 Argentina Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2028)

10.2 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2028)

10.3 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Market Size by Country

10.3.1 Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2028)

10.3.2 Turkey Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

10.3.4 UAE Crohn's Disease Diagnostic and Therapeutic Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Crohn's Disease Diagnostic and Therapeutic Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Crohn's Disease Diagnostic and Therapeutic Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Crohn's Disease Diagnostic and Therapeutic Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) by Region (2017-2022)

Table 5. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Region (2023-2028)

Table 6. AbbVie Corporate Information, Head Office, and Major Competitors

Table 7. AbbVie Major Business

Table 8. AbbVie Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 9. AbbVie Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. Celgene Corporation Corporate Information, Head Office, and Major Competitors

Table 11. Celgene Corporation Major Business

Table 12. Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 13. Celgene Corporation Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Genetech Corporate Information, Head Office, and Major Competitors

Table 15. Genetech Major Business

Table 16. Genetech Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 17. Genetech Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Janssen Biotech Corporate Information, Head Office, and Major Competitors

Table 19. Janssen Biotech Major Business

Table 20. Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 21. Janssen Biotech Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 23. Johnson & Johnson Major Business

Table 24. Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 25. Johnson & Johnson Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Pfizer Corporate Information, Head Office, and Major Competitors

Table 27. Pfizer Major Business

Table 28. Pfizer Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 29. Pfizer Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Prometheus Laboratories Corporate Information, Head Office, and Major Competitors

Table 31. Prometheus Laboratories Major Business

Table 32. Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 33. Prometheus Laboratories Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 34. Salix Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 35. Salix Pharmaceuticals Major Business

Table 36. Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 37. Salix Pharmaceuticals Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 38. Takeda's Pharmaceutical Corporate Information, Head Office, and Major Competitors

Table 39. Takeda's Pharmaceutical Major Business

Table 40. Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Product and Solutions

Table 41. Takeda's Pharmaceutical Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 42. Global Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 43. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 44. Breakdown of Crohn's Disease Diagnostic and Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 45. Crohn's Disease Diagnostic and Therapeutic Players Head Office, Products and Services Provided

Table 46. Crohn's Disease Diagnostic and Therapeutic Mergers & Acquisitions in the Past Five Years

Table 47. Crohn's Disease Diagnostic and Therapeutic New Entrants and Expansion Plans

Table 48. Global Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) by Type (2017-2022)

Table 49. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Type (2017-2022)

Table 50. Global Crohn's Disease Diagnostic and Therapeutic Revenue Forecast by Type (2023-2028)

Table 51. Global Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2022)

Table 52. Global Crohn's Disease Diagnostic and Therapeutic Revenue Forecast by Application (2023-2028)

Table 53. North America Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 54. North America Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 55. North America Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 56. North America Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 57. North America Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 58. North America Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2023-2028) & (USD Million)

Table 59. Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 60. Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 61. Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 62. Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 63. Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 64. Europe Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2023-2028) & (USD Million)

Table 65. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 66. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 67. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 68. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 69. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Region (2017-2022) & (USD Million)

Table 70. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue by Region (2023-2028) & (USD Million)

Table 71. South America Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 72. South America Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 73. South America Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 74. South America Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 75. South America Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 76. South America Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2023-2028) & (USD Million)

Table 77. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2017-2022) & (USD Million)

Table 78. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Type (2023-2028) & (USD Million)

Table 79. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2017-2022) & (USD Million)

Table 80. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Application (2023-2028) & (USD Million)

Table 81. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2017-2022) & (USD Million)

Table 82. Middle East & Africa Crohn's Disease Diagnostic and Therapeutic Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Crohn's Disease Diagnostic and Therapeutic Picture

Figure 2. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Type in 2021

Figure 3. Blood Tests

Figure 4. Fecal Test

Figure 5. Colonoscopy

Figure 6. Flexible Sigmoidoscopy

Figure 7. Computerized Tomography

Figure 8. Magnetic Resonance Imaging

Figure 9. Capsule Endoscopy

Figure 10. Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Application in 2021

Figure 11. Clinic Picture

Figure 12. Hospital Picture

Figure 13. Global Crohn's Disease Diagnostic and Therapeutic Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 14. Global Crohn's Disease Diagnostic and Therapeutic Revenue and Forecast (2017-2028) & (USD Million)

Figure 15. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Region (2017-2028)

Figure 16. Global Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Region in 2021

Figure 17. North America Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Europe Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 20. South America Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 21. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue (USD Million) and Growth Rate (2017-2028)

Figure 22. Crohn's Disease Diagnostic and Therapeutic Market Drivers

Figure 23. Crohn's Disease Diagnostic and Therapeutic Market Restraints

Figure 24. Crohn's Disease Diagnostic and Therapeutic Market Trends

Figure 25. AbbVie Recent Developments and Future Plans

Figure 26. Celgene Corporation Recent Developments and Future Plans

Figure 27. Genetech Recent Developments and Future Plans

Figure 28. Janssen Biotech Recent Developments and Future Plans

Figure 29. Johnson & Johnson Recent Developments and Future Plans

Figure 30. Pfizer Recent Developments and Future Plans

Figure 31. Prometheus Laboratories Recent Developments and Future Plans

Figure 32. Salix Pharmaceuticals Recent Developments and Future Plans

Figure 33. Takeda's Pharmaceutical Recent Developments and Future Plans

Figure 34. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Players in 2021

Figure 35. Crohn's Disease Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 36. Global Top 3 Players Crohn's Disease Diagnostic and Therapeutic Revenue Market Share in 2021

Figure 37. Global Top 10 Players Crohn's Disease Diagnostic and Therapeutic Revenue Market Share in 2021

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 39. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Type in 2021

Figure 40. Global Crohn's Disease Diagnostic and Therapeutic Market Share Forecast by Type (2023-2028)

Figure 41. Global Crohn's Disease Diagnostic and Therapeutic Revenue Share by Application in 2021

Figure 42. Global Crohn's Disease Diagnostic and Therapeutic Market Share Forecast by Application (2023-2028)

Figure 43. North America Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Type (2017-2028)

Figure 44. North America Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Application (2017-2028)

Figure 45. North America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Country (2017-2028)

Figure 46. United States Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Type (2017-2028)

Figure 50. Europe Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Application (2017-2028)

Figure 51. Europe Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Country (2017-2028)

Figure 52. Germany Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Type (2017-2028)

Figure 58. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Region (2017-2028)

Figure 60. China Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 61. Japan Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. South Korea Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. India Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Southeast Asia Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Australia Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. South America Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Type (2017-2028)

Figure 67. South America Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Application (2017-2028)

Figure 68. South America Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Country (2017-2028)

Figure 69. Brazil Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. Argentina Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Type (2017-2028)

Figure 72. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Sales Market Share by Application (2017-2028)

Figure 73. Middle East and Africa Crohn's Disease Diagnostic and Therapeutic Revenue Market Share by Country (2017-2028)

Figure 74. Turkey Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 75. Saudi Arabia Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 76. UAE Crohn's Disease Diagnostic and Therapeutic Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz